NCT06889454View on ClinicalTrials.gov

Cardiovascular and Endothelial Markers During OGTT Before and at Six and Twelve Months Post-treatment in Women With PCOS

RecruitingOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

February 1, 2024

Primary Completion Date

February 1, 2025

Study Completion Date

February 1, 2026

Conditions
PCOSHyperinsulinismHyperandrogenismMetabolic Syndrome
Interventions
DRUG

GLP-1 receptor agonist

30 women will receive lifestyle modification and GLP-1 receptor agonists

DRUG

Oral contraceptive

30 women will receive lifestyle modification and oral contraceptive

DRUG

Metformin

30 women will receive lifestyle modification and metformin

OTHER

Lifestyle modification

30 women will receive only lifestyle modification

Trial Locations (1)

124 62

RECRUITING

Attikon University General Hospital, Chaïdári

All Listed Sponsors
lead

Attikon Hospital

OTHER